Riskpilot← Back to searchSign inGet full accessLabio Medical AB
ABActiveOrg 5562548502StockholmResearch and experimental development on natural sciences and engineering · NACE 7210Est. 19850 employees
Revenue 2024
SEK 0
EBITDA margin
—
+51% vs 2023
Equity ratio
94.7%
Financial strength
Net profit 2024
SEK -1,7M
+36% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -1,2M | +51% |
| Net profit | SEK -1,7M | +36% |
| Total assets | SEK 2,8M | -48% |
| Equity | SEK 2,7M | -13% |
| Employees | 0 | — |
Legal name
Labio Medical AB
Org number
5562548502
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
6 februari 1985
Share capital
SEK 1 419 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Brännhammar, Carl Vilhelm Edward Firman tecknas i förening av ledamöterna
Company purpose
Föremålet för bolagets verksamhet skall vara att utveckla, patentera och kommersialisera en teknik för att på ett enkelt, säkert och kostnadseffektivt sätt kunna analysera utandningsluft samt att bedriva därmed förenlig verksamhet.
Address
Stockholm
Email
info@labio.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 30 | 93 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | — | −686 | −93 | −2 473 | −1 205 |
| Depreciation & amort. | −0 | −154 | −159 | −165 | −183 |
| EBIT | 0 | −840 | −252 | −2 638 | −1 388 |
| Net financials | — | — | — | — | −293 |
| Profit before tax | 0 | −840 | −252 | −2 638 | −1 681 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −840 | −252 | −2 638 | −1 681 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 0 | 831 | 614 | 5 408 | 2 820 |
| Equity | −9 | 303 | 51 | 3 080 | 2 671 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 9 | 528 | 563 | 2 328 | 149 |
| Total debt | 9 | 528 | 563 | 2 328 | 149 |
EBITDA margin
-120500000.0%
This company
15.8%
Market median
-762658328% vs market
20202024
Equity ratio
94.7%
This company
38.2%
Market median
+148% vs market
20202024
Return on equity
-62.9%
This company
18.4%
Market median
-442% vs market
20202024
Net profit margin
-168100000.0%
This company
8.1%
Market median
-2075308742% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
LA Audit | Audit | 2020 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2023 | |
| Deputy Board Member | 2022 | |
| Former (4) | ||
| Board of Directors | 2023 – 2023 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Labio Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Anders Karlsson | Audit | 0 companies |
| Daniel Thomas Schilling | Board of Directors | 0 companies |
| Ylva C M d l A Nicolae Santesson | Board of Directors | 0 companies |
| Carl Ulf Botolfs | Board of Directors | 0 companies |
| Fredrik Roger Zettergren | Board of Directors | 0 companies |
| Carl Vilhelm Edward Brännhammar | Chairman | 0 companies |
| Per Olof Vilhelm Brännhammar | Deputy Board Member | 0 companies |
| Hanna Katarzyna Wojtysiak | Board of Directors | 0 companies |